NASDAQ:ELOX | Free Cash Flow | Eloxx Pharmaceuticals, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2010-09-30 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$5.45M
2025-03-31$1.2M
2023-12-31-$2.01M
2023-03-31-$6.81M$0.00-$6.81M
2022-12-31-$5.66M$0.00-$5.66M
2022-03-31-$9.49M$11,000.00-$9.5M
2021-12-31-$9.93M$20,000.00-$9.95M
2021-03-31-$7.69M
2020-12-31-$4.67M
2020-03-31-$11.92M
2019-12-31-$9.26M$0.00-$9.26M
2019-03-31-$9.19M$16,000.00-$9.2M
2018-12-31-$9.06M$102,000.00-$9.16M
2018-03-31-$5.7M$57,000.00-$5.75M
2017-12-31-$6.27M$82,000.00-$6.35M
2017-09-30-$575,324.00
2017-06-30-$508,752.00$0.00-$508,752.00
2017-03-31-$2.73M$74,000.00-$2.81M
2016-09-30-$573,744.00
2016-06-30-$714,786.00$0.00-$714,786.00
2015-09-30-$1.13M$0.00-$1.13M
2015-06-30-$2.42M$5,383.00-$2.43M
2014-09-30-$1.94M$74,327.00-$2.01M
2014-06-30-$1.22M$3,194.00-$1.22M
2013-09-30-$670,465.00$0.00-$670,465.00
2013-06-30-$946,328.00$0.00-$946,328.00
2012-09-30-$636,454.00$1,281.00-$637,735.00
2012-06-30-$1.11M$0.00-$1.11M
2011-09-30-$1.09M
2011-06-30-$1.02M$0.00-$1.02M
2010-09-30-$1.61M$2,026.00-$1.61M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$6.33M
2024-12-31-$4.72M
2023-12-31-$14.34M
2022-12-31-$31.85M$66,000.00-$31.91M
2021-12-31-$35M$89,000.00-$35.09M
2020-12-31-$28.17M
2019-12-31-$39.39M$40,000.00-$39.43M
2018-12-31-$31.37M$235,000.00-$31.6M
2017-12-31-$15.94M$237,000.00-$16.17M
2017-06-30-$1.93M$2,500.00-$1.93M
2016-12-31-$8.84M$36,000.00-$8.88M
2016-06-30-$3.68M$0.00-$3.68M
2015-12-31-$5.74M$10,000.00-$5.75M
2015-06-30-$7.34M$122,641.00-$7.47M
2014-06-30-$4.87M$3,194.00-$4.87M
2013-06-30-$3.9M$1,281.00-$3.9M
2012-06-30-$4.39M$4,461.00-$4.39M
2011-06-30-$5.39M$2,026.00-$5.39M